SABC Research Program

Greetings to all at the Scleroderma Ride for Research at Stanley Park (16 Jun 2024) from Drs. Dunne, Kim, and Keen . We are absent this year because of attending to present our research, but there will be a message read from us!

EULAR 2024 has wrapped in Vienna. Check out the photo of the World Scleroderma Foundation display at . The abstract for the poster can be found via the following link.
https://congress.eular.org/abstract_archive.cfm

The poster presentation by Dr. Kevin Keen Group on Wed 12 Jun 2024 went 20 minutes over the 60-minute timeslot! Rheumatologists Drs. Hyein Kim and James Dunne were there with Dr. Keen.

Just arrived at the Convention Centre (Messe) for in Vienna. Our poster session will be at 15h30 - 16h30 this afternoon (Wed 12 Jun 2024)! Representing the Group are Drs. Dunne, Keen, and Kim.

The abstract for our poster presentation at EULAR 2024 on Wed 12 Jun 2024 in Vienna, Austria, has just been published and is available for viewing here.

https://scientific.sparx-ip.net/archiveeular/?searchfor=POS0556&view=1&c=a&item=2024POS0556

Let us know what you think!

Our poster's abstract for the 8th Systemic Sclerosis World congress has been published online by the "Journal of Scleroderma and Related Disorders" and is available for viewing or download at the following web address.
https://journals.sagepub.com/toc/jsoa/9/1_suppl

Memories of members of SABC Research Program at the Centre for Heart Lung Innovation of two weeks ago in Prague at the 8th Systemic Sclerosis World Congress. Can you name the members who were there?

Members of SABC Research Program are in Prague for the start of the 8th Systemic Sclerosis World Congress.

The final program for the 8th Systemic Sclerosis World Congress is available for download at the following web address.

https://web.aimgroupinternational.com/2024/sclerosiscongress/programme/

On page 44 you will find the entry for Poster P.364 by the SABC Research Program at Centre for Heart Lung Innovation !

The December 2023 quarterly progress report of the SABC Research Program based at St. Paul's Hospital is now available on the Scleroderma Association of B.C. website at the following web address.

https://sclerodermabc.ca/research/sabc-research-program/

The SABC Research Program at the Centre for Heart Lung Innovation just had an abstract accepted for poster presentation (No. P.364) at the 8th Systemic Sclerosis World Congress in Prague in March 2024! More details after the embargo on publication is lifted when the conference starts.

We are looking forward to seeing everyone on Saturday for the Annual General Meeting & Conference of the Scleroderma Association of B.C. and giving an update on our research activities!

The June 2023 Quarterly Progress Report of the Program is available online at the Scleroderma Association of B.C. website at: https://sclerodermabc.ca/research/sabc-research-program/

To mark World Scleroderma Day you can read a lay summary of our latest research on systemic scleroderma and ILD (interstitial lung disease) published at https://doi.org/10.26685/urncst.442 by going to the the Scleroderma Association of B.C. webpage: https://sclerodermabc.ca/research/sabc-research-program/.

Read our latest research on dysregulations of the RNA inference pathway important for processing microRNA in patients with systemic scleroderma or ILD (interstitial lung disease), or both, published in the "Undergraduate Research in Natural and Clinical Sciences Journal" at https://doi.org/10.26685/urncst.442

Have you SharedIt? Our research in Scientific Reports on scleroderma and pulmonary fibrosis is free to read. Share the link to help others learn more about scleroderma and interstitial lung disease: https://rdcu.be/daAJ5

In 2020, reseachers https://doi.org/10.1371/journal.pone.0241719 found levels of serum cytokine CXCL9 to be higher in collagen vascular disease patients with interstitial lung disease (ILD) compared to patients with idiopathic pulmonary fibrosis. Our recent research https://rdcu.be/daAJ5 showed the same for patients with limited cutaneous scleroderma (SSc) and ILD. SSc is one of the collagen vascular diseases. CXCL9 promotes immune cell migration into tissue and profibrotic signaling.

For a lay summary of our recent article in Scientific Reports on differential expression of cytokines in scleroderma and interstitial lung disease, please go to https://sclerodermabc.ca/research/sabc-research-project/ on the Scleroderma Association of B.C. website. For the full article ... Read more here: https://rdcu.be/daAJ5

Our latest research on systemic scleroderma and interstitial lung disease has just been published with Springer Nature in Scientific Reports. Read here: https://rdcu.be/daAJ5

The authors of our lastest research https://rdcu.be/daAJ5 on scleroderma and ILD (interstitial lung disease) are based at St. Paul's Hospital with the Centre for Heart Lung Innovation of Providence Research and have appointments with The University of British Columbia, The University of Northern British Columbia, The University of Calgary, and McGill University with thanks to staff at St. Paul's Foundation.

Many thanks to the Scleroderma Association of B.C. for the funding that made the research possible for our article on cytokines in scleroderma and interstitial lung disease just published in Scientific Reports! Read the article here: https://rdcu.be/daAJ5

We at the SABC Research Program are looking forward to seeing everyone at the 2022 Annual General Meeting & Conference of the Scleroderma Ass'n of BC tomorrow (Saturday the 22nd of October) at 8:30 a.m. via Zoom! For more information or to register go to https://sclerodermabc.ca/.

Many thanks to Basak (Ashley) Sahin, a research technician at the Molecular Phenotyping Core Lab of the Centre for Heart Lung Innovation at St. Paul’s Hospital , who is one of the tireless workers for the SABC Research Program.

The Quarterly Progress Report for June 2022 (our 20th Quarterly Report) for the SABC Research Program can be found at: https://sclerodermabc.ca/sabc-research-project/

The 2022 Annual Congress of The European Alliance of Associations for Rheumatology is occurring in Copenhagen, Denmark, and online through 4 June. Two members of are attending with a digital research poster presentation given by Dr. Boyang Zheng.

For those wanting to know more about the newest member of the leadership team for the SABC Research Program, Beth Miller had a successful bilateral lung transplant in the summer of 2020 and is active with the Board of the Scleroderma Association of BC.

The Quarterly Progress Report for March 2022 for the SABC Research Program can be found at: https://sclerodermabc.ca/sabc-research-project/